Pregabalin Capsule
Product Images NDC 80425-0025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 1

Fig 1
FDA Label Image

Fig 10

Fig 10
FDA Label Image

Fig 11

Fig 11
FDA Label Image

Fig 12

Fig 12
FDA Label Image

Fig 2

Fig 2
FDA Label Image

Fig 3

Fig 3
FDA Label Image

Fig 4

Fig 4
Percentage of patients who improved their pain from baseline after receiving Pregabalin 200mg three times a day, Pregabalin 100mg three times a day or a placebo is indicated by the text "Percentage Improvement In Pain from Baseline". However, the accuracy of the text is questionable due to errors.*
FDA Label Image

Fig 5

Fig 5
FDA Label Image

Fig 6

Fig 6
This appears to be a table or chart with information from multiple studies, measures, and doses of a drug compared to a placebo. It seems to indicate the percentage of patients in each study who had a certain outcome, but without any context or label for what that outcome is. The text also notes that some of the results were statistically significant compared to the placebo group. Without further information, it is not possible to provide a more specific or useful description.*
FDA Label Image

Fig 7

Fig 7
FDA Label Image

Fig 9

Fig 9
This appears to be a chart showing the percentage of patients who experienced improvement in pain levels when taking different doses of Pregabalin. There are four different dose levels shown: 100mg/day, 300mg/day, 450mg/day, and a placebo. The chart shows the percentage of patients who experienced improvement in pain levels in comparison to their baseline pain level.*
FDA Label Image

Formula

Formula
This text is a mathematical formula to estimate creatinine clearance (CLCr) in patients. The formula depends on the patient's age, weight and gender, as well as the level of creatinine in their serum. However, without additional context, it is unclear what purpose this formula serves or in what medical situations it might be used.*
FDA Label Image

Pregabalin 50 mg Cap Qty 30 80425 0025

Pregabalin 50 mg Cap Qty 30 80425 0025
FDA Label Image

Pregabalin 50 mg Cap Qty 60 80425 0025

Pregabalin 50 mg Cap Qty 60 80425 0025
FDA Label Image

Pregabalin 50 mg Cap Qty 90 80425 0025

Pregabalin 50 mg Cap Qty 90 80425 0025
FDA Label Image

Structure

Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.